magic mushrooms

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial

This research paper has been published in eClinicalMedicine. The summary says: “Background Psilocybin has been suggested as a novel, rapid-acting treatment for depression. Two consecutive doses have been shown to markedly decrease symptom severity in an open-label setting or when compared to…
Read more

Magic-mushroom drug can treat severe depression, trial suggests

This report by Philippa Roxby comes from the BBC. It begins: “A drug based on a compound in hallucinogenic mushrooms can improve the symptoms of severe depression for up to 12 weeks, a trial shows. A 25mg tablet of psilocybin puts…
Read more

Psilocybin: Magic mushroom compound ‘promising’ for depression

Rachel Schraer reports for the BBC: “Dr Carhart-Harris said that after psychedelic therapy, participants reported feeling ‘recalibrated, reset like they haven’t for years” and “enjoying life’.” “Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression…
Read more

‘Magic mushrooms’ could avert looming mental health crisis, says North Wales police boss

“The fact that psilocybin is classified as a Class A drug means there has been a research blackout for nearly 50 years into the beneficial effect it can have in improving the lives of people suffering from PTSD and depression.”Arfon…
Read more

The case for funding psychedelics to treat mental health

“Scientists are developing psilocybin, the active ingredient in magic mushrooms, into a treatment for depression.” Reporting for Vox, Sigal Samuel writes : “… drugs like traditional antidepressants are, at best,  only a partial solution . While their effectiveness has been hotly contested over the past…
Read more

Magic mushrooms could help ex-soldiers to overcome trauma

Writing in The Guardian, Jamie Doward reports : “A growing number of soldiers suffering from post-traumatic stress disorder are turning to ‘magic mushrooms’ and LSD to treat their condition. But drug laws make it almost impossible to establish whether they work….
Read more

Psychiatry & the psychedelic drugs. Past, present & future

Written by James Rucker, Jonathan Iliff and David Nutt, the abstract of this article (2017, Neuropharmacology) says: “The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and mescaline, were used extensively in psychiatry before they were placed in Schedule I of the…
Read more

Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential

This article –  Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential – appeared in the British Medical Journal (May 2015). It was written by Dr. James Rucker (specialist registrar in adult psychiatry). The article summary…
Read more

Follow

Get the latest posts delivered to your mailbox:

Your email address will not be passed to any other organisation. It will only be used to send you new posts made on this website.

MENU